Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Novel Insights Into The Non-Small Cell Lung Can...

Non-small cell lung cancer (NSCLC) is the most common cancer, accounting for approximately 85% of all lung cancers. As per the American Cancer Society, almost 230K new cases were diagnosed in 2022 ...

Nov 14, 2022

emerging-therapies-for-cutaneous-t-cell-lymphoma-treatment
How Will the Emerging Therapies for Cutaneous T-cell Lymphoma Reshuffle its Treatment Landscape

Cutaneous T-cell lymphoma (CTCLs) characterized by cutaneous infiltration of malignant monoclonal T-lymphocytes is a rare lymphoma affecting around 6.4 cases per million individuals every year. The total incident population of Cutaneous T-cell lymphoma in the 7MM was around 7.5K in 2021, with the US accounting for ...

Find More
Hemophilia A Market Forecast and Assessment
Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape

Hemophilia A treatment scenario before the launch of HEMLIBRA Despite the ups and downs throughout history, the management of hemophilia A patients substantially improved over the past 40 years. The groundbreaking discovery of cryoprecipitate in 1964 marked the beginning of the modern progression of hemophilia t...

Find More
evolving-als-treatment-landscape
How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape?

Mitsubishi replacing RADICAVA’s Intravenous (IV) formulation with Oral. Opinion on Amylyx Pharma’s recent approval, RELYVRIO  The amyotrophic lateral sclerosis treatment landscape is stringent and includes multidisciplinary care, such as physical therapy, speech therapy, dietary counseling, heat or whirlpoo...

Find More

More Views & Analysis

clinical-diagnostics-market-outlook
Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market

Clinical Diagnosis (Dx) is the identification and confirmation of disease or disorder or exposure to xenobiotics to explain the clinical manifestations shown by the patient. It is also performed to assess the state of health of an individual (routine health checkup), functioning of any organ or associated metabolic...

Find More

humira-biosimilars-in-psoriatic-arthritis-treatment-market
HUMIRA Biosimilars in the US: The Talk of the Psoriatic Arthritis Treatment Market

Psoriatic arthritis (PsA) is a type of chronic inflammatory arthritis that affects approximately 1 in every 10 people with psoriasis. According to the National Psoriasis Foundation, psoriasis is most common in adults aged 30 to 50. However, psoriatic arthritis can develop at any age, including children. Accordin...

Find More

non-opioid-analgesics-for-chronic-pain-treatment
Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients

Chronic pain is the leading cause of adult disability in the United States. Approximately 50 million Americans are currently suffering from chronic pain. The most common sources of chronic pain are lower back problems, arthritis, cancer, RSDS, repetitive stress injuries, shingles, headaches, and fibromyalgia. Other...

Find More

alpha-1-antitrypsin-deficiency-treatment-market
Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market

In the 21st century, public health has yielded major advances in understanding and managing diseases. Sometimes, early diagnosis remains crucial in managing and treating a serious condition. One such rare genetic disorder, alpha-1 antitrypsin deficiency (AATD), has witnessed improvements concerning awareness and co...

Find More

Emerging Trends and Technologies in the Dental Care Market
Evaluating the Key Trends and Technologies Shaping the Future of Dentistry

Oral diseases, while largely preventable, are one of the major health burdens globally and affect about 3.5 billion people. Dental caries or cavities (commonly known as tooth decay) and gum (periodontal) disease are the most common conditions that severely affect oral health and account for the most considerable pa...

Find More

oncolytic-viruses-for-cancer-treatment
Oncolytic Viruses: Can Be The Next Frontier in Cancer Immunotherapy?

Oncolytic viruses are cancer treatments that employ a natural or reprogrammed virus capable of targeting and killing malignant cells. They are a new class of cancer agents that induce tumor regression by causing immunogenic cell death, inducing preferential replication in tumor cells, and stimulating host antitumor...

Find More

Value-Based Healthcare is that healthcare model or a process where the providers, including hospital.....

Find More

Cell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....

Find More

Spinal Cord Injury (SCI) causes extreme back pain and at times triggers an “accelerating aging” .....

Find More

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification .....

Find More

Dry Age-related Macular Degeneration (Dry AMD), also called atrophic AMD, is the most common form of.....

Find More

Myocardial infarction (MI), colloquially known as “heart attack” is caused by decreased or compl.....

Find More